skip to Main Content

Novel Protocol Improves Pancreatic Cancer Outcomes

Novel Protocol Improves Pancreatic Cancer Outcomes
Locally advanced pancreatic cancer (LAPC) — a tumor that, while still confined to the pancreas, involves major abdominal blood vessels — is one of the worst forms of an already deadly tumor, as it cannot be removed surgically.

Now a Massachusetts General Hospital (MGH) Cancer Center clinical trial of a treatment protocol combining intensive chemotherapy and radiation with the blood-pressure drug losartan has produced unprecedented results, allowing complete removal of the tumor in 61 percent of participants and significantly improving survival rates. Read more . . .

 


Back To Top